Management of Recurrent Glioblastomas: What Can We Learn from the French Glioblastoma Biobank?

SIMPLE SUMMARY: There is no broad consensus concerning the management of recurrent glioblastoma (rGB). Within the French GB biobank (FGB), systemic treatment is the principal second-line treatment. None of the systemic treatment regimens was unequivocally better than the others for rGB patients. An...

Descripción completa

Detalles Bibliográficos
Autores principales: Clavreul, Anne, Autier, Lila, Lemée, Jean-Michel, Augereau, Paule, Soulard, Gwénaëlle, Bauchet, Luc, Figarella-Branger, Dominique, Menei, Philippe, Network, FGB
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688811/
https://www.ncbi.nlm.nih.gov/pubmed/36428604
http://dx.doi.org/10.3390/cancers14225510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688811/
https://www.ncbi.nlm.nih.gov/pubmed/36428604
http://dx.doi.org/10.3390/cancers14225510

Ejemplares similares